Finance

Lists
Why is OMDA down 2.52%?
Dive Deeper
OMDA:NASDAQ
Omada Health Inc
$14.33
-2.52%
(-0.37) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OMDA...
Open
$14.82
High
$14.88
Low
$14.18
Mkt. cap
889.00M
Avg. vol.
1.25M
Volume
1.21M
P/E ratio
217.88
52-wk high
$25.44
52-wk low
$10.28
EPS
$0.07
Shares outstanding
62.04M
No. of employees
980
Open
$14.82
High
$14.88
Low
$14.18
Mkt. cap
889.00M
Avg. vol.
1.25M
Volume
1.21M
P/E ratio
217.88
52-wk high
$25.44
52-wk low
$10.28
EPS
$0.07
Shares outstanding
62.04M
No. of employees
980
News stories
From web sources and news partners
About Omada Health Inc
CEO-
Employees980
Founded2011
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 9 analysts giving stock ratings to OMDA in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for OMDA in the last 3 months.
Highest
Current $14.33
$35.00 (+144.24%)
Average
$27.33 (+90.72%)
Lowest
$19.00 (+32.59%)
Analyst
Recommendation
Action
Price target
Projected
Date
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
$30.00
+109.4%
11/09/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
$28.00
+95.4%
11/06/2026
Sean Dodge
BMO Capital
Buy
Maintained
$24.00
+67.5%
11/05/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
$19.00
+32.6%
11/05/2026
David Larsen
BTIG
Buy
Reiterated
$35.00
+144.2%
11/05/2026
Saket Kalia
Barclays
Buy
Maintained
$22.00
+53.5%
11/06/2026
Eugene Mannheimer
Freedom Capital Markets
Buy
Reiterated
$35.00
+144.2%
09/14/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$25.00
+74.5%
09/11/2026
Ryan MacDonald
Needham
Buy
Reiterated
$28.00
+95.4%
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$30.00
+109.4%
08/14/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$27.00
+88.4%
07/20/2026
David Roman
Goldman Sachs
Buy
Maintained
$25.00
+74.5%
06/10/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$0.21 / $0.10
+114.27%beat
Revenue / Est. (USD)
91.31M / 85.64M
+6.62%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
75.85M
78.05M
87.84M
91.31M
Cost of goods sold
22.18M
29.36M
24.05M
22.02M
Cost of revenue
22.18M
29.36M
24.05M
22.02M
Research and development expenses
11.55M
12.70M
14.62M
15.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.83M
40.78M
45.61M
49.19M
Operating expense
50.38M
53.47M
60.24M
64.46M
Total operating expenses
72.56M
82.83M
84.29M
86.49M
Operating income
3.28M
-4.78M
3.55M
4.82M
Other non operating income
-
-
-
-
EBT including unusual items
5.16M
-2.97M
5.29M
6.55M
EBT excluding unusual items
5.16M
-2.97M
5.29M
6.55M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
5.16M
-2.97M
5.29M
6.55M
Net profit margin
6.80%
-3.81%
6.03%
7.17%
Earnings per share
0.16
0.05
0.20
0.21
Interest and investment income
1.89M
1.83M
1.76M
1.99M
Interest expense
-13.00K
-18.00K
-14.00K
-262.00K
Net interest expenses
1.88M
1.81M
1.74M
1.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
4.73M
-3.27M
5.13M
6.50M
Gain or loss from assets sale
6.00K
2.00K
25.00K
27.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps